Percutaneous Coronary Intervention Registry FRIBOURG

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age17-120
SponsorUniversity of Freiburg

About this trial

The registry aims to follow clinically all consecutive patients treated by percutaneous coronary interventions at hospital \& university Fribourg.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

All consecutive patients treated by percutaneous coronary intervention at our institution

Able to give informed consent and willing to participate

Disqualifiers

Unwillingness to participate

Enable to provide inform consent

Trial population

All comers

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • Percutaneous coronary intervention, stents

    Device

Treatment groups

No treatment groups listed

Trial outcomes

Primary outcomes

1

Patient-oriented composite endpoints (POCE)

Academic Research Consortium definition

Time frame
2 years
2

Major Bleeding

Bleeding Academic Research Consortium definition

Time frame
2 years
3

Patient-oriented composite endpoints (POCE)

Academic Research Consortium definition

Time frame
5 years
4

Major Bleeding

Bleeding Academic Research Consortium definition

Time frame
5 years

Secondary outcomes

1

all-cause death

Academic Research Consortium definition

Time frame
2 years
2

any revascularization

Academic Research Consortium definition

Time frame
2 years
3

any myocardial infarction

Academic Research Consortium definition

Time frame
2 years

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.